These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 3840014)

  • 21. Graves' ophthalmopathy. Correlation of saccadic eye movements with age, presence of optic neuropathy, and extraocular muscle volume.
    Feldon SE; Levin L; Liu SK
    Arch Ophthalmol; 1990 Nov; 108(11):1568-71. PubMed ID: 2244842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum levels of soluble Fas in patients with Graves' ophthalmopathy.
    Ohtsuka K; Hashimoto M
    Br J Ophthalmol; 2000 Jan; 84(1):103-6. PubMed ID: 10611108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE; Levin L
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lid retraction and levator aponeurosis defects in Graves' eye disease.
    Frueh BR; Musch DC; Garber FW
    Ophthalmic Surg; 1986 Apr; 17(4):216-20. PubMed ID: 3754942
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quantitative CT of the orbit in Graves' disease.
    Ozgen A; Alp MN; Ariyürek M; Tütüncü NB; Can I; Günalp I
    Br J Radiol; 1999 Aug; 72(860):757-62. PubMed ID: 10624341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased muscle tension and reduced elasticity of affected muscles in recent-onset Graves' disease caused primarily by active muscle contraction.
    Simonsz HJ; Kommerell G
    Doc Ophthalmol; 1989 Aug; 72(3-4):215-24. PubMed ID: 2625083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Serum antibodies against the flavoprotein subunit of succinate dehydrogenase are sensitive markers of eye muscle autoimmunity in patients with Graves' hyperthyroidism.
    Gunji K; De Bellis A; Kubota S; Swanson J; Wengrowicz S; Cochran B; Ackrell BA; Salvi M; Bellastella A; Bizzarro A; Sinisi AA; Wall JR
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1255-62. PubMed ID: 10199764
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease.
    Noh JY; Hamada N; Inoue Y; Abe Y; Ito K; Ito K
    Thyroid; 2000 Sep; 10(9):809-13. PubMed ID: 11041459
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study of serum antibodies against three eye muscle antigens and the connective tissue antigen collagen XIII in patients with Graves' disease with and without ophthalmopathy: correlation with clinical features.
    Gopinath B; Musselman R; Adams CL; Tani J; Beard N; Wall JR
    Thyroid; 2006 Oct; 16(10):967-74. PubMed ID: 17042681
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Graves' eye disease: orbital compliance and other physical measurements.
    Frueh BR
    Trans Am Ophthalmol Soc; 1984; 82():492-598. PubMed ID: 6398935
    [No Abstract]   [Full Text] [Related]  

  • 31. Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation.
    Alp MN; Ozgen A; Can I; Cakar P; Gunalp I
    Br J Ophthalmol; 2000 Sep; 84(9):1027-30. PubMed ID: 10966959
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Upgaze intraocular pressure changes and strabismus in Graves' ophthalmopathy.
    Fishman DR; Benes SC
    J Clin Neuroophthalmol; 1991 Sep; 11(3):162-5. PubMed ID: 1836798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Graves' ophthalmopathy: II. Correlation of clinical signs with measures derived from computed tomography.
    Hallin ES; Feldon SE
    Br J Ophthalmol; 1988 Sep; 72(9):678-82. PubMed ID: 3179255
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE; Lee CP; Muramatsu SK; Weiner JM
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Sonography of the retrobulbar space in autoimmune hyperthyroidism of the Basedow type].
    Schillings S; Wagner J; Franzen W; Wildmeister W
    Z Gesamte Inn Med; 1990 Nov; 45(22):678-83. PubMed ID: 2099028
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F; Zamboni G; Cerini R; Lauriola S; Dall'Agnola A; Tatò L
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Graves' ophthalmopathy].
    Badelon I; Morax S
    Rev Prat; 2005 Jan; 55(2):183-6. PubMed ID: 15826000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Radioiodine therapy and Graves' ophthalmopathy.
    Sisson JC; Schipper MJ; Nelson CC; Freitas JE; Frueh BR
    J Nucl Med; 2008 Jun; 49(6):923-30. PubMed ID: 18483104
    [TBL] [Abstract][Full Text] [Related]  

  • 39. IgA autoantibodies against human eye muscle antigen detected by western blotting and immunohistochemical methods in Graves' disease.
    Molnár I; Kaczur V; Boros A; Krajczár G; Balázs C
    J Endocrinol Invest; 1995 Jun; 18(6):408-14. PubMed ID: 7594233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical significance of extraocular muscle volumes in Graves' ophthalmopathy: a quantitative computed tomography study.
    Feldon SE; Weiner JM
    Arch Ophthalmol; 1982 Aug; 100(8):1266-9. PubMed ID: 6896638
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.